No Data
No Data
Express News | Renovaro Inc -on Sept 12, Got Deficiency Notice From Nasdaq on Failure to Satisfy Continued Listing Rule or Standard
Independent Expert Assessment Validates RenovaroCube's Potential as a Groundbreaking AI Platform Starting With Early Cancer Detection
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
Sector Update: Health Care Stocks Softer in Afternoon Trading
Renovaro Offering 20% Stake in Cancer-Diagnostics Subsidiary to Investors; Shares Tumble
Renovaro: Terms to Be Determined With Potential RenovaroCube Investors as Potentially Identified >RENB